Avivagen Inc VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Comment by drilltip1on Feb 23, 2012 12:28pm

92 Views

Post# 19573849

RE: RE: RE: RE: Carbanx

I don't know what the dollar potential is for the chewable tablets for dogs is in the USA but I imagine when we get introduced into the feed supply for poultry and swine the dollar value is quite large.

It's clear however that the market sees this at 13 cents or so for the time being, it will take a couple months is a logical guess to really get it moving, todays news said Later this year for the implimentation of the tablets, does that mean November or July or something like that, the market obvioulsly feels there is lots of time to get in as the trading activity would indicate.

This will be news driven that's for sure so all we need is time. Is it a fair bet that CFR will be showing some revenue in calander Q4, any thoughts on that or will it show in Q1 2013

Bullboard Posts

Canadian artificial intelligence ETFs